Frontlight ResearchEarly access
Asthma trials in Spain
43 of 48 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- Where
- Alcorcón, Badalona, Barcelona, Esplugues de Llobregat, Girona, Granada, Logroño, Lugo, Madrid, Palma, Pamplona, Pozuelo de Alarcón, Santander, Sevilla, Valencia, Zaragoza
- Age
- 12 years and over
- People
- 456 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07456033 · EU 2025-524463-20-00 - Phase 3Active, not recruitingEfficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
- Where
- Barcelona, Esplugues de Llobregat, Jerez de la Frontera, Madrid, Sabadell, Santiago de Compostela, Valencia
- Age
- 2 years to 5 years
- People
- 90 worldwide
- Run by
- Sanofi
See details and how to joinNCT06191315 · EU 2023-504331-41-00 - Phase 3Taking peopleA Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1)
- Where
- Badalona, Barcelona, Huelva, Leganés, L'hospitalet De Llobregat, Málaga, Mataro, Peralada, Pontevedra, Santiago de Compostela, Sevilla, Valencia, Zaragoza
- People
- 80 worldwide
- Run by
- Generate Biomedicines Inc.
See details and how to join2025-524040-35-00 - Phase 3Not yet taking people in SpainA double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.
- Where
- Badalona, Barcelona, Esplugues de Llobregat, Sabadell, Santiago de Compostela, Sevilla
- Age
- Up to 17 years
- People
- 68 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2022-502365-26-00 - Phase 4Not yet taking people in SpainBETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
- Where
- Badalona, Barcelona, Benalmádena, Madrid, Marbella, Sevilla, Zaragoza
- Age
- 18 years and over
- People
- 644 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07666490 · EU 2025-524289-56-00 - Phase 3Taking peopleClinical trial to assess the efficacy and safety of a vaccine for dust mite and Lepidoglyphus destructor allergy.
- Where
- A Coruña, Alicante, Barcelona, Burela, Cadiz, Córdoba, Ferrol, Lugo, Ourense, Plasencia, Pontevedra, Sant Joan d'Alacant, Sevilla
- People
- 120
- Run by
- Inmunotek S.L.
See details and how to join2025-522771-28-00 - Phase 3Taking peoplePhase III clinical trial to evaluate the efficacy and safety of specific immunotherapy with mannanconjugated allergoids for the treatment of rhinitis/rhinoconjunctivitis in patients allergic to house dust mites.
- Where
- Alicante, Badajoz, Barcelona, Cadiz, Elche, Ibiza, Las Palmas de Gran Canaria, Lorca, Malaga, Málaga, Valencia, Vigo
- People
- 250 worldwide
- Run by
- Inmunotek S.L.
See details and how to join2023-508548-23-00 - Phase 3Taking peopleGrass Immunotherapy for Rhinitis and Asthma (GIRA)
- Where
- Albacete, Alcorcón, Aranjuez, Ávila, Badajoz, Barcelona, Castello De La Plana, Cuenca, Elche, Fuenlabrada, Girona, Guadalajara, Leganés, Lleida, Llíria, Madrid, Majadahonda, Málaga, Manresa, Ourense, Pamplona, Plasencia, Pontevedra, Salamanca, Sevilla, Talavera De La Reina, Terrassa, Valencia, Valladolid, Vic, Zaragoza
- People
- 324 worldwide
- Run by
- LETI Pharma S.L.U.
See details and how to join2025-521736-10-00 - Phase 3Taking peoplePhase III clinical trial to evaluate the efficacy and safety of specific immunotherapy with mannanconjugated allergoids for the treatment of rhinitis/rhinoconjunctivitis in patients allergic to house dust mites.
- Where
- Alicante, Esplugues De Llobregat, La Laguna, Málaga, Melilla, Sant Joan d'Alacant, Sevilla, Terrassa, Villarreal
- People
- 250 worldwide
- Run by
- Inmunotek S.L.
See details and how to join2023-508547-51-00 - Phase 3Taking peopleGrass/Olive Immunotherapy for Rhinitis and Asthma (GOES)
- Where
- Albacete, Alcorcón, Almería, Aranjuez, Ávila, Badajoz, Barcelona, Castello De La Plana, Córdoba, Cuenca, Elche, Fuenlabrada, Girona, Granada, Guadalajara, Leganés, Lleida, Madrid, Majadahonda, Málaga, Móstoles, Murcia, Pamplona, Plasencia, Salamanca, San Sebastián de los Reyes, Sevilla, Talavera De La Reina, Terrassa, Valencia, Valladolid, Vic
- People
- 343 worldwide
- Run by
- LETI Pharma S.L.U.
See details and how to join2025-521709-42-00 - Phase 3Taking peopleDepemokimab Asthma Imaging and Bronchoscopy Sub-Study
- Where
- Barcelona, Benalmádena, L'hospitalet De Llobregat, Madrid, Palma, Santander, Valencia
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06979323 · EU 2024-519976-19-00 - No phaseTaking peopleDASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions
- Where
- Seville
- Age
- 18 years and over
- People
- 280
- Run by
- Adhera Health, Inc.
See details and how to joinNCT07638345 - No phaseTaking peopleEmoTIChealth: Promoting Adolescent Health Through a Serious Game.
- Where
- Valencia
- Age
- 12 years to 16 years
- People
- 600
- Run by
- University of Valencia
See details and how to joinNCT07212530 - Phase 3Taking peopleEfficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
- Where
- Alicante, Benidorm
- Age
- 12 years to 65 years
- People
- 736 worldwide
- Run by
- Inmunotek S.L.
See details and how to joinNCT07348302 - Phase 3CompletedEfficacy and Safety Evaluation for the Treatment of Allergy Against Mites
- Where
- Algeciras (Cádiz), Alicante, Badajoz, Barcelona, Cartagena, Córdoba, Lugo, Málaga, Melilla, Puerto de Santa María (Cádiz), Sagunto, Santander, Santiago de Compostela, Sevilla, Torrevieja, Valencia, Vigo, Clínica Privada en Murcia
- Age
- 12 years to 65 years
- People
- 150
- Run by
- Inmunotek S.L.
See details and how to joinNCT04435990 · EU 2024-514090-21-00 - Phase 3Taking peopleEfficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
- Where
- Ávila, Burgos, Collado Villalba, Cuenca, Madrid, Murcia, Pozuelo de Alarcón, Salamanca, Segovia, Torrelodones, Valladolid
- Age
- 12 years to 65 years
- People
- 180
- Run by
- Inmunotek S.L.
See details and how to joinNCT04898283 · EU 2024-514524-16-00 - Phase 3Active, not recruitingEfficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
- Where
- Ávila, Badajoz, Barcelona, Ciudad Real, Córdoba, Granada, Jaén, Lleida, Madrid, Málaga, Murcia, Palencia, Parla, Sevilla, Tarancón (Cuenca), Tres Cantos (Madrid), Valdemoro (Madrid), Valladolid
- Age
- 12 years to 65 years
- People
- 180
- Run by
- Inmunotek S.L.
See details and how to joinNCT04891237 · EU 2024-514525-34-00 - Phase 4Not yet taking people in SpainOmalizumab's dose reduction or increase in the frequency of administration in patients who suffer from allergic severe asthma
- Where
- Barcelona
- Age
- 18 years and over
- People
- 110
- Run by
- Consorci Mar Parc De Salut De Barcelona
See details and how to join2025-520782-48-00